FH and hereditary leiomyomatosis and renal cell cancer: FH-deficient RCC is a renal tumor newly defined by the WHO (5th edition) in 2022 [1] and was named hereditary leiomyomatosis renal cell carcinoma (HLRCC)-associated RCC by the WHO (4th edition) in 2016 [8].